VistaGen Therapeutics, Inc.
GENETIC VARIANTS ASSOCIATED WITH RESPONSE TO TREATMENT OF NEUROLOGICAL DISORDERS

Last updated:

Abstract:

Method of treating depression, major depressive disorder, suicidal ideation and related disorders are described by administering L-4-chlorokynurenine (L-4-CI-KYN) to a subject based on their genotype.

Status:
Application
Type:

Utility

Filling date:

9 Apr 2020

Issue date:

30 Jun 2022